Velocity Clinical Research

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Idiopathic pulmonary fibrosis1 trial
• Obesity1 trial

Phase

• Phase 21 trial
• Phase 41 trial

Status

• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Currax Pharmaceuticals1 trial
• Pliant Therapeutics, Inc.1 trial

Running trials

• Active, not recruiting

  Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

  NCT06098079· Phase 4· Currax Pharmaceuticals· Source

Closed trials

• Terminated

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· Phase 2· Pliant Therapeutics, Inc.· Source